VIDAS Kube

The U.S. Food and Drug Administration (FDA) is seeking a VIDAS Kube automated immunoassay system to support research, method development, and validation activities. The system must meet specific technical requirements, including being a modular, automated immunoassay platform with an integrated control interface, utilizing Enzyme-Linked Fluorescent Immunoassay (ELFA) technology, and providing automated processing, flexible throughput, and accurate results. The contract will be a Firm Fixed-Price (FFP) award, with a period of performance beginning upon award and continuing through delivery, installation, and a one-year warranty period. • The system must be a modular, automated immunoassay platform • The system must utilize Enzyme-Linked Fluorescent Immunoassay (ELFA) technology • The system must provide automated processing, including incubation, washing, and detection • The system must deliver accurate, reproducible, and sensitive analytical results • The system must include an intuitive user interface and minimize hands-on time and operator intervention • The system must include built-in quality control and system diagnostics